US Patent Issued to CENTESSA PHARMACEUTICALS (UK) on May 12 for "4-((6-oxopyrimidin-1(6H)-yl)methyl)benzoic acid as an inducer of Z A1AT secretion for treating AATD" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,008, issued on May 12, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain).

"4-((6-oxopyrimidin-1(6H)-yl)methyl)benzoic acid as an inducer of Z A1AT secretion for treating AATD" was invented by Nigel Ramsden (Babraham, Great Britain), David John Fox (Babraham, Great Britain) and James Andrew Huntington (Altrincham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to 4-((6-oxopyrimidin-1(6H)-yl)methyl)benzoic acid, compositions thereof, and uses of either, for example in the treatment of Alpha1-antitrypsin deficiency (A1AD or AATD)."

The patent was filed on Dec. 15, 2022, under Application ...